Since 1940, Taiwan has carried out the Local-self Goverment system, Township¡]Country/Town/City¡^has been the front line status of local authority. Because the Constitution does not expressly protect the autonomous status, together with the practical operation of manipulation of local factions and the drawbacks of corruption, as well as the lack of people, money, lack of influence of factors such as the right, resulting in poor functional autonomy, therefore the cancellation of legal status, and that the abolition of self-government elections have been put forward, and caused heated discussion and debate from all walks of life, due to support and oppose the two factions has its own rationale, controversy over the years has not yet come to a conclusion. In this paper, analysis of the Department to collect the relevant papers, periodicals, books, letters Release Act, the meeting information, network information, such as newspapers and magazines as a source of research data and study the use of the rule of law, historical research, secondary data analysis based supplemented by participant observation method of research methods, to be on view. The present paper is divided into five chapters. The first chapter includes introduction, background studies, the motive, the goal, the research framework and the method on this article. The second chapter deliberates origin, the localization and the connotation and the law transformation of the township autonomous status of Autonomous bodies. The third chapter analyzes and explains the design, the implementation and the development of Autonomous bodies. The fourth chapter focuses on the form, the argument of the system, the populace view and analysis of system transformation. The fifth chapter, a conclusion, provides an outcome of the studies, and attempts to propose a strategic solution to the question that has been brought up.

Do dying patients have a moral claim to access experimental drugs when all else has failed? This question has been the focus of an active and evolving debate concerning the rights of terminally ill patients, the nature of the drug development process, and the scope of federal regulation, with supporters arguing that seriously ill patients should be able to decide for themselves whether and when to attempt experimental therapies and opponents arguing that the resulting state of affairs would be disastrous for patient safety and for the integrity of the drug development process. This thesis concerns the ethical considerations surrounding the provision of experimental drugs for treatmentoften termed compassionate use or expanded accessand argues that compelling ethical merits on both sides of the debate complicate the formation of satisfactory public policy. Although patient autonomy is often invoked to support liberal access to experimental drugs, the paucity of known information about investigational compounds as well as the unique vulnerability of the terminally ill patient call into question the wisdom of the unfettered exercise of autonomy in this context. Although equitable distribution of experimental drugs is often felt to be a concern, the meaning of equity in this context has not been clearly defined, and in fact several working concepts of equitable access may not be achievable or desirable. Although the financial burden on drug manufacturers is frequently recognized as a barrier to expanded access, the potential for expanded access programs to constitute a marketing strategy should be recognized, and the mixing of profit motives with altruistic ones brought to light. Parsing these and other ethical nuances points to certain ways in which policies governing expanded access can be refined to allow for access while maximizing patient protection and ensuring the generation of scientific knowledge. Physicians, as frequent mediators of requests for experimental drugs, should be knowledgeable of the ethical issues inherent and should help to ensure the judicious use of experimental therapies. Finally, general misconceptions about the benefits of experimental therapy, pervasive in our culture, heighten the contentiousness of this debate. A workable legislative solution should be accompanied by a thoughtful and deliberate effort to educate patients, their advocates, and broader society about the realistic pace of drug development and the limits of modern medicine. This thesis recognizes that individuals who seek expanded access often have valid moral claims to do so, but advocates a cautious attitude toward the dissemination of experimental drugs for treatment and maintains the importance of government and physician participation in adjudicating access.

Thesis(Ph.D.)--Case Western Reserve University, 2010 / Title from PDF (viewed on 2010-01-28) Department of Bioethics Includes abstract Includes bibliographical references and appendices Available online via the OhioLINK ETD Center

Thesis (M.P.A.)--Kutztown University of Pennsylvania, 2002. / Source: Masters Abstracts International, Volume: 45-06, page: 2949. Typescript. Abstract precedes thesis as 2 preliminary leaves. Includes bibliographical references (leaves 68-71).

Thesis ( Ph.D. ) -- University of Texas at Arlington, 2008.

Thesis (Ph. D.)--University of Washington, 2001. / Vita. Includes bibliographical references (leaves 212-216).

Thesis (Ph. D.)--University of Texas at Austin, 2000. / Vita. Includes bibliographical references (leaves 157-164). Available also in a digital version from Dissertation Abstracts.

Thesis (Ph. D.)--University of Washington, 2003. / Vita. Includes bibliographical references (p. 136-139).

published_or_final_version / Education / Doctoral / Doctor of Philosophy

Not available / text